These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35172939)

  • 21. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery for high-risk locally advanced (pT3c) renal tumours: oncological outcomes and prognostic significance of a modified International Metastatic Renal Cell Cancer Database Consortium (IMDC) score.
    Warren H; Fernando A; Thomas K; Austin C; Chowdhury S; O'Brien T
    BJU Int; 2019 Sep; 124(3):462-468. PubMed ID: 30908845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
    Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
    Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy.
    Staník M; Poprach A; Littnerová S; Čapák I; Hulová M; Šebová N; Lakomý R; Jarkovský J; Doležel J
    Urol Oncol; 2022 Mar; 40(3):111.e27-111.e34. PubMed ID: 34961683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC).
    Marchioni M; Kriegmair M; Heck M; Amiel T; Porpiglia F; Ceccucci E; Campi R; Minervini A; Mari A; Van Bruwaene S; Linares E; Hevia V; Musquera M; D'Anna M; Derweesh I; Bradshaw A; Autorino R; Guruli G; Veccia A; Roussel E; Albersen M; Pavan N; Claps F; Antonelli A; Palumbo C; Klatte T; Erdem S; Mir MC;
    Eur Urol Oncol; 2021 Apr; 4(2):256-263. PubMed ID: 33384274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone metastasis is associated with poor prognosis in metastatic papillary renal cell carcinoma patients treated with first agent angiogenesis inhibitors.
    Haaker L; Tryssesoone L; Renders I; Verbiest A; Lerut E; Baldewijns M; Bourgain C; Roussel E; Van den Bulck H; Wynendaele W; Laguerre B; Rioux-Leclercq N; Oudard S; Laenen A; Debruyne PR; Albersen M; Beuselinck B
    Urol Oncol; 2020 Aug; 38(8):686.e1-686.e9. PubMed ID: 32430250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
    Eggener SE; Yossepowitch O; Pettus JA; Snyder ME; Motzer RJ; Russo P
    J Clin Oncol; 2006 Jul; 24(19):3101-6. PubMed ID: 16809736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative.
    Shiff B; Breau RH; Mallick R; Pouliot F; So A; Tanguay S; Kapoor A; Lattouf JB; Lavallée L; Fairey A; Finelli A; Bhindi B; Kawakami J; Rendon R; Bansal RK
    Urol Oncol; 2021 Dec; 39(12):836.e19-836.e27. PubMed ID: 34556430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
    Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF; Wood CG; Karam JA
    J Urol; 2017 Aug; 198(2):281-288. PubMed ID: 28268170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy.
    Zhou L; Chang Y; Xu L; Liu Z; Fu Q; Yang Y; Lin Z; Xu J
    J Urol; 2016 Aug; 196(2):335-42. PubMed ID: 26970566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma.
    Beisland C; Gudbrandsdottir G; Reisæter LA; Bostad L; Wentzel-Larsen T; Hjelle KM
    Scand J Urol; 2015 Jun; 49(3):205-10. PubMed ID: 25423093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
    May M; Surcel C; Capitanio U; Dell'Oglio P; Klatte T; Shariat S; Ecke T; Wolff I; Vergho D; Wagener N; Huck N; Pahernik S; Zastrow S; Wirth M; Borgmann H; Haferkamp A; Musquera M; Krabbe LM; Herrmann E; Scavuzzo A; Mirvald C; Hutterer G; Zigeuner R; Stief CG; Waidelich R; Cindolo L; Kalusova K; Brookman-May SD;
    Scand J Urol; 2017 Aug; 51(4):269-276. PubMed ID: 28399699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival And Progression After Radical Nephrectomy In A Cohort Of Non-Metastatic Renal Cell Carcinoma Treated With Curative Intent.
    Khan N; Irshad Khalil MA; Ali A; Manzoor S; Urooj N; Mir K
    J Ayub Med Coll Abbottabad; 2019; 31(3):314-319. PubMed ID: 31535497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):449-450. PubMed ID: 28416109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A preoperative clinical prognostic model for non-metastatic renal cell carcinoma.
    Cindolo L; de la Taille A; Messina G; Romis L; Abbou CC; Altieri V; Rodriguez A; Patard JJ
    BJU Int; 2003 Dec; 92(9):901-5. PubMed ID: 14632843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.